期刊文献+

甲状腺及乳房多原发癌病人甲状腺癌组织WIF-1基因mRNA表达及其启动子甲基化状态分析 被引量:1

mRNA EXPRESSION AND PROMOTER METHYLATION OF WIF-1 GENE IN THYROID CANCER TISSUES OF PATIENTS WITH MULTIPLE PRIMARY CARCINOMAS OF BREAST AND THYROID
下载PDF
导出
摘要 目的探讨甲状腺、乳房多原发癌病人甲状腺癌组织WIF-1基因mRNA表达及其启动子的甲基化状态。方法采用RT-PCR及甲基化特异性PCR(MSP)方法检测33例甲状腺、乳房多原发癌病人甲状腺癌组织WIF-1基因mRNA表达及其启动子甲基化状态,以30例单纯甲状腺乳头状癌和20例甲状腺良性病变组织作为对照。结果多原发癌病人甲状腺癌组织、单纯甲状腺乳头状癌组织和甲状腺良性病变组织WIF-1基因的表达缺失率分别为51.5%(17/33)、36.7%(11/30)、15.0%(3/20),3组比较差异有统计学意义(χ2=7.105,P<0.05)。多原发癌病人甲状腺癌组织、单纯甲状腺乳头状癌组织WIF-1基因的甲基化率分别为45%(15/33)、43%(13/30),高于甲状腺良性病变组织的10%(2/20),差异有显著性(χ2=6.349、7.185,P<0.01),但多原发癌病人甲状腺癌组织与单纯甲状腺乳头状癌组织相比差异无显著性(P>0.05)。结论 WIF-1基因mRNA表达缺失在甲状腺、乳房多原发癌的发生过程中起关键作用;WIF-1基因启动子区的高甲基化状态可能是其mRNA低表达的机制之一。 Objective To investigate mRNA expression and the promoter methylation of WIF-1 gene in thyroid cancer tissue of patients with multiple primary carcinoma of thyroid (MPCT) and breast. Methods The mRNA expression and the pro- moter methylation of WIF-1 gene in 33 cases of thyroid cancer tissues in patients with multiple primary breast cancer (MPBC) and MPCT were analyzed by reverse transcription PCR (RT-PCR) and methylation specific PCR, and 30 cases of simple papillary thy- roid carcinoma (SPTC) tissues and 20 cases of benign thyroid (BT) tissues served as controls. Results The gene deletion rates of WIF-1 expressions in MPCT, SPTC and BT were 51.5% (17/33), 36.7% (11/30) and 15.0% (3/20), respectively, the diffe- rence between the three groups being significant (X2=7.105 ,P〈0.05). Methylation of WlF-1 gene in MPCT and SPTC was 45% (15/33) and 43% (13/30), respectively, which were higher than 10% (2/20) of BT, the difference being significant (X2 =6.349, 7.185;P〈〈0.01), but there was no significant difference between MPCT and SPTC (P〉0.05). Conclusion The absence of WIF-1 gene mRNA expression plays a key role in the process of the occurrence of multiple primary carcinomas in breast and thy roid. The promoter hypermethylation of WIF-1 gene is likely to be one of the mechanisms of low expression of its mRNA.
出处 《齐鲁医学杂志》 2015年第2期144-146,共3页 Medical Journal of Qilu
关键词 肿瘤 多原发性 甲状腺肿瘤 乳房肿瘤 WIF-1 DNA甲基化 neoplasms, multiple primary thyroid neoplasms breast neoplasms WIF-1 DNA methylation
  • 相关文献

参考文献8

  • 1FUSCO A, CHIAPPETTA G, HUI P, et al. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence o{ papillary carcino- ma: a search for the early precursors of papillary cancer-. Am J Pathol, 2002,160(6) :2157-2167.
  • 2HERMAN J G, BAYLIN S B. Gene silencing in cancer in as- sociation with promoter hypermethylation[J]. N Engl J Med, 2003,349(21) :2042-2054.
  • 3SMYTH P P, SMITH D F, MCDERMOTT E W, et al. A di- rect relationship between thyroid enlargement and breast can- cer[J]. J Clin Endocrinol Metab, 1996,81(3):937-941.
  • 4MICHALAKI V, KONDI-PAFITI A, GENNATAS S, et al. Breast cancer in association with thyroid disorders E J . ] BUON, 2009,14(3) :425-428.
  • 5钟源,江学庆,李海,张晓毅.二例乳腺及甲状腺多原发癌[J].中华内分泌外科杂志,2012,6(1):36-37. 被引量:5
  • 6MAZIERES J, HE B, YOU L, et aL Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer I-J]. Cancer Res, 2004,64(14) ..4717-4720.
  • 7BATRA S, SHI Y, KUCHENBECKER K M, et al. Wnt in- hibitory {actor-l, a Writ antagonist, is silenced by promoter hypermethy[ation {n malignant pleura[ mesothelioma[J]. Bio- chem Biophys Res Commun, 2006,342(4) : 1228-1232.
  • 8LIN Y C, YOU L, XU Z, et al. Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines[J]. Bio- chem Biophys Res Commun, 2006,341(2)1635-640.

二级参考文献9

  • 1姜淑云,张乃武,周珊珊,王建璋.多原发恶性肿瘤的探讨[J].河北医学,1996,2(3):198-202. 被引量:7
  • 2Warren S, Gates O. Multiple primary malignant tumors, a survey of the literature and a statistical study[J]. Am J Cancer,1932,16 (2) :1358-1363.
  • 3Dong C, Hemminki K. Multiple primary cancers of colon, breast and skin melanoma as models for polygenic cancers [ J ]. Int J Cancer,2001,92(6) :883-887.
  • 4Wamakulasuriya KA, Robinson D, Evans H. Multiple primary tumors following head and neck cancer in southern England during 1961-1998 [ J ]. J Oral Pathol Med,2003,32 ( 8 ) :443-449.
  • 5Park JS, Oh KK, Kim EK, et al. Sonographic detection of thyroid cancer in breast cancer patients[ J]. Yonsei Med J,2007,48 ( 1 ) :63-68.
  • 6Duchateau CS, Stokkel MP. Second primary tumors involving nonsmallcell lung cancer:prevalence and it influence on survival [ J ]. Chest,2005,127 (4) : 1152-1158.
  • 7Giani C, Fierabracci P, Bonacci R, et al. Relationship between breast cancer and thyroid disease:relevance of autoimmune thyroid disorders in breast malignancy [ J ]. J Clin Endocrinol Metab, 1996,81 ( 3 ) :990-994.
  • 8Turken O, Narln Y, Demlrbas S, et al. Breast cancer in association with thyroid disorders [ J]. Breast Cancer Res,2003,5 (5): 110-113.
  • 9Kawabata W, Suzuki T, Moriya T, et al. Estrogen receptors (alpha and beta) and 17 beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders:possible in situ estrogen synthesis and actions[J]. Mod Pathol,2003,16(5) :437-444.

共引文献4

同被引文献13

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部